Delayed reactivation of chronic infantile neurologic, cutaneous, articular syndrome (CINCA) in a patient with somatic mosaicism of CIAS1/NLRP3 gene after withdrawal of anti-IL-1 beta therapy

Clin Exp Rheumatol. 2015 Sep-Oct;33(5):766. Epub 2015 Aug 27.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Humanized
  • Carrier Proteins / genetics*
  • Cryopyrin-Associated Periodic Syndromes / diagnosis
  • Cryopyrin-Associated Periodic Syndromes / drug therapy*
  • Cryopyrin-Associated Periodic Syndromes / genetics
  • Cryopyrin-Associated Periodic Syndromes / immunology
  • Drug Administration Schedule
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Interleukin 1 Receptor Antagonist Protein / administration & dosage*
  • Interleukin-1beta / antagonists & inhibitors*
  • Interleukin-1beta / immunology
  • Mosaicism*
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Phenotype
  • Recurrence
  • Remission Induction
  • Time Factors
  • Treatment Outcome
  • Young Adult

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Carrier Proteins
  • IL1B protein, human
  • Immunosuppressive Agents
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1beta
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • NLRP3 protein, human
  • canakinumab